Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Community Bank
CBU
$3.43B
| $1.24M | ﹤0.01% |
23,753
+12,869
| +118% | +$754K |
|
|
NARI
1502
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $1.24M | ﹤0.01% |
20,155
+12,783
| +173% | +$767K |
|
1503
Huntington Ingalls Industries
HII
$12.9B
| $1.24M | ﹤0.01% |
6,007
+1,200
| +25% | +$259K |
|
1504
MaxLinear
MXL
$6.74B
| $1.24M | ﹤0.01% |
35,327
+20,936
| +145% | +$758K |
|
|
RVNC
1505
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.24M | ﹤0.01% |
38,626
+24,831
| +180% | +$774K |
|
1506
Enovis
ENOV
$1.42B
| $1.24M | ﹤0.01% |
23,235
+15,005
| +182% | +$869K |
|
1507
NMI Holdings
NMIH
$3.38B
| $1.24M | ﹤0.01% |
55,525
+26,363
| +90% | +$591K |
|
1508
Resideo Technologies
REZI
$3.89B
| $1.24M | ﹤0.01% |
67,751
+43,234
| +176% | +$782K |
|
1509
International Money Express
IMXI
$343M
| $1.23M | ﹤0.01% |
47,879
+4,416
| +10% | +$107K |
|
|
EXAS
1510
DELISTED
Exact Sciences
EXAS
| $1.23M | ﹤0.01% |
18,196
-1,317
| -7% | -$84.7K |
|
1511
Integer Holdings
ITGR
$4.25B
| $1.23M | ﹤0.01% |
15,920
+10,426
| +190% | +$764K |
|
1512
Park Hotels & Resorts
PK
$2.99B
| $1.23M | ﹤0.01% |
99,819
+54,144
| +119% | +$711K |
|
|
SEM
1513
DELISTED
Select Medical
SEM
| $1.23M | ﹤0.01% |
88,620
+47,962
| +118% | +$706K |
|
1514
UMB Financial
UMBF
$11.4B
| $1.23M | ﹤0.01% |
21,294
+14,768
| +226% | +$1.2M |
|
1515
Clearway Energy Class C
CWEN
$7.06B
| $1.22M | ﹤0.01% |
39,088
+23,324
| +148% | +$749K |
|
1516
Zscaler
ZS
$28.7B
| $1.22M | ﹤0.01% |
10,469
+18
| +0.2% | +$2.16K |
|
|
FWAC
1517
DELISTED
Fifth Wall Acquisition Corp. III Class A Ordinary Shares
FWAC
| $1.22M | ﹤0.01% |
119,738
| – | – |
|
|
COOP
1518
DELISTED
Mr. Cooper
COOP
| $1.22M | ﹤0.01% |
29,816
+16,329
| +121% | +$716K |
|
1519
United Parks & Resorts
PRKS
$2.01B
| $1.22M | ﹤0.01% |
19,835
+10,726
| +118% | +$655K |
|
|
ESGR
1520
DELISTED
Enstar Group
ESGR
| $1.21M | ﹤0.01% |
5,251
+3,297
| +169% | +$781K |
|
1521
Carter's
CRI
$1.43B
| $1.21M | ﹤0.01% |
16,840
+9,366
| +125% | +$717K |
|
1522
Cogent Communications
CCOI
$525M
| $1.21M | ﹤0.01% |
18,987
+10,353
| +120% | +$666K |
|
1523
Hertz
HTZ
$998M
| $1.21M | ﹤0.01% |
74,199
+37,360
| +101% | +$652K |
|
1524
National Vision
EYE
$1.54B
| $1.21M | ﹤0.01% |
64,127
-1,880,791
| -97% | -$61.2M |
|
|
THS
1525
DELISTED
Treehouse Foods
THS
| $1.2M | ﹤0.01% |
23,769
+14,587
| +159% | +$706K |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.